Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.35 |
| ▸ | RAB9A | P51151 | 4/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1107847 | 0.93 | ATM (0.43) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL1096470 | 0.84 | ATM (0.41) | MAPTATMMEN1KMT2ALMNA | |
| SCHEMBL1107830 | 0.84 | ATM (0.39) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL14000969 | 0.83 | ATM (0.41) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL14000960 | 0.82 | ATM (0.43) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL14000967 | 0.80 | ATM (0.40) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL14000958 | 0.79 | ATM (0.41) | MAPTATMMEN1KMT2ALMNA | |
| SCHEMBL1107826 | 0.78 | ALDH1A1 (0.40) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL3415134 | 0.78 | MAPT (0.44) | MAPTATMHPGDMEN1KMT2A | |
| SCHEMBL14000948 | 0.77 | ATM (0.42) | MAPTATMHPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153560-B2 | Pesticidal active mixtures comprising aminothiazoline compounds | BASF SE (DE) | 2012-04-10 | — | — | US | disclosed |
| US-8153560-B2 | Pesticidal active mixtures comprising aminothiazoline compounds | BASF SE (DE) | 2012-04-10 | — | — | US | disclosed |
| US-20100056469-A1 | Pesticidal Active Mixtures Comprising Aminothiazoline Compounds | BASF SE (DE) | 2010-03-04 | — | — | US | disclosed |
| US-20100056469-A1 | Pesticidal Active Mixtures Comprising Aminothiazoline Compounds | BASF SE (DE) | 2010-03-04 | — | — | US | disclosed |
| WO-2008104503-A1 | PESTICIDAL ACTIVE MIXTURES COMPRISING AMINOTHIAZOLINE COMPOUNDS | BASF SE (DE) | 2008-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056469-A1 | Pesticidal Active Mixtures Comprising Aminothiazoline Compounds | ACHE, PTMS, CHRM3 | MAPT 2950/4885ATM 917/4885HPGD 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.